The most enriched GO items suggest the remarkable role of RNA splicing in the mechanism of FUBP1 across different cancer types, and the small-molecule splicing modulators that are currently in clinical trials offer a promising approach to cancer therapy. Here, FUBP1 is linked to cancer.